A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo. (2022)
Attributed to:
Quatitative proteomic analysis of castrate-resistant prostate cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.1c01733
PubMed Identifier: 34979089
Publication URI: http://europepmc.org/abstract/MED/34979089
Type: Journal Article/Review
Volume: 65
Parent Publication: Journal of medicinal chemistry
Issue: 1
ISSN: 0022-2623